Naproxen
EC-NAPROXEN, Naprelan, Naproxen, Rugby All Day Relief
Nonsteroidal Anti-inflammatory Drug
NADAC/unit
$0.0459
No Shortage
Tier 1: 336.8%
17 Manufacturers
50 ANDAs
Naproxen reduces pain, inflammation, and fever by inhibiting prostaglandin synthesis.
vs. brand EC-NAPROXEN: Generic saves up to 100% per unit
Market Intelligence
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2023-12-06 Class II Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
ACTAVIS LABORATORIES FL INCADAPTIS PHARMA PRIVATE LTDAMNEAL PHARMACEUTICALS LLCAMNEAL PHARMACEUTICALS NY LLCATNAHS PHARMA US LTDAUROBINDO PHARMA LTDAUROBINDO PHARMA USA INCDR REDDYS LABORATORIES LTDGLENMARK PHARMACEUTICALS LTDGRANULES INDIA LTDHETERO LABS LTD UNIT IIIHIKMA PHARMACEUTICALS USA INCNOVITIUM PHARMA LLCNUVO PHAMACEUTICALS INCSCIEGEN PHARMACEUTICALS INCTEVA PHARMACEUTICALS USA INCTP ANDA HOLDINGS LLCTWI PHARMACEUTICALS INCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.